Canon Medical Systems Corp., of Otawara, Japan, reported the opening of its Middle East Division in Canon Middle East Dubai, United Arab Emirates. Preparations are underway to start business operations around the beginning of January 2020. Madison, Wis.-based Exact Sciences Corp. said that in collaboration with Mayo Clinic, it has initiated the Voyage study to generate evidence of the real-world impact of Cologuard on colorectal cancer screening, incidence and mortality rates. Voyage is a prospective, observational study designed to enroll more than 150,000 people with a valid Cologuard order and follow them for at least seven years to evaluate clinical outcomes.